Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Kiora Pharmaceuticals (KPRX) Return on Capital Employed (2016 - 2025)

Kiora Pharmaceuticals' Return on Capital Employed history spans 10 years, with the latest figure at 0.55% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 69.0% year-over-year to 0.55%; the TTM value through Dec 2025 reached 0.55%, down 69.0%, while the annual FY2025 figure was 0.48%, 72.0% down from the prior year.
  • Return on Capital Employed reached 0.55% in Q4 2025 per KPRX's latest filing, down from 0.29% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.14% in Q4 2024 to a low of 1.18% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.51%, with a median of 0.46% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: tumbled -72bps in 2022, then skyrocketed 110bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.67% in 2021, then crashed by -76bps to 1.18% in 2022, then increased by 19bps to 0.96% in 2023, then surged by 115bps to 0.14% in 2024, then tumbled by -482bps to 0.55% in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Return on Capital Employed are 0.55% (Q4 2025), 0.29% (Q3 2025), and 0.37% (Q2 2025).